Biomedico Hadarim Ltd
Augwind Energy Tech, a technology company, offers compression, expansion, and storage solutions for energy storage and energy efficiency applications in Israel. The company offers AirBattery, an energy storage system that is a combination of pumped hydro and compressed air energy storage to enable grid-scale energy storage; water compressors; AirSmart, an energy efficiency solution for air compre… Read more
Biomedico Hadarim Ltd (ITGMF) - Total Liabilities
Latest total liabilities as of June 2025: $12.78 Million USD
Based on the latest financial reports, Biomedico Hadarim Ltd (ITGMF) has total liabilities worth $12.78 Million USD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Biomedico Hadarim Ltd - Total Liabilities Trend (2018–2024)
This chart illustrates how Biomedico Hadarim Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Biomedico Hadarim Ltd Competitors by Total Liabilities
The table below lists competitors of Biomedico Hadarim Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
OXE Marine AB (publ)
PINK:CMMCF
|
USA | $112.46 Million |
|
Lion Metal Works Tbk
JK:LION
|
Indonesia | Rp135.92 Billion |
|
Doré Copper Mining Corp
OTCQB:DRCMF
|
USA | $2.15 Million |
|
Surge Components Inc
PINK:SPRS
|
USA | $6.29 Million |
|
Acumentis Group Ltd
AU:ACU
|
Australia | AU$12.24 Million |
|
Renrenle Commercial Group Co Ltd
SHE:002336
|
China | CN¥2.06 Billion |
|
Victor Group Holdings Ltd
AU:VIG
|
Australia | AU$6.95 Million |
Liability Composition Analysis (2018–2024)
This chart breaks down Biomedico Hadarim Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.27 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.26 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.21 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Biomedico Hadarim Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Biomedico Hadarim Ltd (2018–2024)
The table below shows the annual total liabilities of Biomedico Hadarim Ltd from 2018 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $13.65 Million | -16.14% |
| 2023-12-31 | $16.27 Million | -35.81% |
| 2022-12-31 | $25.35 Million | -14.91% |
| 2021-12-31 | $29.79 Million | +168.27% |
| 2020-12-31 | $11.11 Million | +26.81% |
| 2019-12-31 | $8.76 Million | +5305.56% |
| 2018-12-31 | $162.00K | -- |